Literature DB >> 20805928

More than Medication-Achieving Goals through Psychotherapy in Patients with Obsessive Compulsive Disorder.

J Scott Wilson, Brenda Jb Roman.   

Abstract

There are numerous variables to consider when planning treatment for a psychiatric disorder as complex as obsessive compulive disorder (OCD). Beyond the efficacy of the medications, one must take into account patient preferences and beliefs, as well as the impact of the disease and treatment on social and occupational functioning. Psychotherapy, specifically cognitive behavioral therapy (CBT), can serve as an addition to pharmacotherapy or as an alternative treatment, if necessary, for OCD. However, psychotherapy remains under-utilized. In this article, the authors review the available evidence supporting various treatment options for OCD and describe how psychotherapy (specifically CBT) can be used as monotherapy for OCD or as an adjunct to medication. Effective strategies for delivering CBT via its two modalities (exposure-response prevention and cognitive therapy) are described and illustrated by a composite case.

Entities:  

Keywords:  cognitive behavior therapy; obsessive compulsive disorder; psychotherapy

Year:  2007        PMID: 20805928      PMCID: PMC2922390     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  29 in total

1.  Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder.

Authors:  L M Koran; A L Ringold; M A Elliott
Journal:  J Clin Psychiatry       Date:  2000-07       Impact factor: 4.384

2.  Psychosurgery: a historical overview.

Authors:  R P Feldman; J T Goodrich
Journal:  Neurosurgery       Date:  2001-03       Impact factor: 4.654

Review 3.  Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.

Authors:  W K Goodman; H Ward; A Kablinger; T Murphy
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

4.  Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment.

Authors:  Nienke H Tenneij; Harold J G M van Megen; Damiaan A J P Denys; Herman G M Westenberg
Journal:  J Clin Psychiatry       Date:  2005-09       Impact factor: 4.384

5.  Cognitive assessment of obsessive-compulsive disorder. Obsessive Compulsive Cognitions Working Group.

Authors: 
Journal:  Behav Res Ther       Date:  1997-07

6.  Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.

Authors:  J Zohar; R Judge
Journal:  Br J Psychiatry       Date:  1996-10       Impact factor: 9.319

7.  Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder.

Authors:  P van Oppen; E de Haan; A J van Balkom; P Spinhoven; K Hoogduin; R van Dyck
Journal:  Behav Res Ther       Date:  1995-05

8.  Clinical comparison of Tourette's disorder and obsessive-compulsive disorder.

Authors:  R K Pitman; R C Green; M A Jenike; M M Mesulam
Journal:  Am J Psychiatry       Date:  1987-09       Impact factor: 18.112

9.  Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.

Authors: 
Journal:  Arch Gen Psychiatry       Date:  1991-08

10.  Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.

Authors:  H L Leonard; S E Swedo; J L Rapoport; E V Koby; M C Lenane; D L Cheslow; S D Hamburger
Journal:  Arch Gen Psychiatry       Date:  1989-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.